Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL7811103 | 0.90 | CHRM2 (0.43) | CHRM2CHRM1 | |
| Fumaric Acid SCHEMBL7811107 | 0.90 | CHRM2 (0.43) | CHRM2CHRM1 | |
| SCHEMBL7811117 | 0.90 | CHRM2 (0.46) | CHRM2CHRM1 | |
| SCHEMBL7818388 | 0.88 | CHRM2 (0.48) | CHRM2 | |
| SCHEMBL7811511 | 0.86 | CHRM1 (0.62) | CHRM1 | |
| SCHEMBL8195856 | 0.86 | CHRM1 (0.54) | CHRM1 | |
| SCHEMBL7818484 | 0.86 | CHRM1 (0.56) | CHRM2CHRM1 | |
| Hydrochloric Acid SCHEMBL8200001 | 0.85 | CHRM1 (0.53) | CHRM1 | |
| Oxalic Acid SCHEMBL7819837 | 0.85 | CHRM2 (0.44) | CHRM2CHRM1 | |
| Vedaclidine SCHEMBL995360 | 0.84 | CHRM1 (0.63) | CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6281233-B1 | AZABICYCLIC RING-SUBSTITUTED THIA- OR OXADIAZOLES | NOVO NORDISK A/S (DK) | 2001-08-28 | — | — | US | claimed |
| EP-0714394-B1 | ANTIPSYCHOTIC METHOD WITH THIADIAZOLE AND OXADIAZOLE DERIVATIVES | NOVO NORDISK AS (DK) | 2001-06-20 | — | — | EP | claimed |
| EP-0873124-A1 | A METHOD OF TREATING HYPERCHOLESTEROLEMIA AND RELATED DISORDERS | NOVO NORDISK A/S (DK) | 1998-10-28 | — | — | EP | claimed |
| EP-0790995-A1 | A METHOD OF TREATING URINARY BLADDER DYSFUNCTIONS | NOVO NORDISK A/S (DK) | 1997-08-27 | — | — | EP | claimed |
| WO-1997025043-A1 | A METHOD OF TREATING HYPERCHOLESTEROLEMIA AND RELATED DISORDERS | NOVO NORDISK A/S (DK) | 1997-07-17 | — | — | WO | claimed |
| EP-0735869-A1 | A METHOD OF TREATING GASTROINTESTINAL MOTILITY DISORDERS | NOVO NORDISK A/S (DK) | 1996-10-09 | — | — | EP | claimed |
| EP-0714394-A1 | ANTIPSYCHOTIC METHOD | NOVO NORDISK A/S (DK) | 1996-06-05 | — | — | EP | claimed |
| WO-1996014316-A1 | A METHOD OF TREATING URINARY BLADDER DYSFUNCTIONS | NOVO NORDISK A/S (DK) | 1996-05-17 | — | — | WO | claimed |
| EP-0687266-A1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1995-12-20 | — | — | EP | claimed |
| WO-1995017180-A1 | A METHOD OF TREATING GASTROINTESTINAL MOTILITY DISORDERS | NOVO NORDISK A/S (DK) | 1995-06-29 | — | — | WO | claimed |
| WO-1995005379-A1 | ANTIPSYCHOTIC METHOD | NOVO NORDISK A/S (DK) | 1995-02-23 | — | — | WO | claimed |
| WO-1994020496-A1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1994-09-15 | — | — | WO | claimed |
| EP-0709093-B1 | Method for treating anxiety using an azabicyclic oxadiazole or thiadiazole compound | LILLY CO ELI (US) | 2000-04-05 | — | — | EP | disclosed |
| WO-1996013166-A1 | METHOD FOR TREATING ANXIETY | ELI LILLY AND COMPANY (US) | 1996-05-09 | — | — | WO | disclosed |
| EP-0709093-A2 | Method for treating anxiety using an azabicyclic oxadiazole or thiadiazole compound | ELI LILLY AND COMPANY (US) | 1996-05-01 | — | — | EP | disclosed |
| US-5484794-A | THIA- OR OXA-DIAZOLE COMPOUNDS | ELI LILLY AND COMPANY (US) | 1996-01-16 | — | — | US | disclosed |